Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Debt Ratio (2017 - 2021)

Sunshine Biopharma (SBFM) has disclosed Debt Ratio for 5 consecutive years, with 0.86 as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Debt Ratio fell 4.98% year-over-year to 0.86, compared with a TTM value of 0.86 through Dec 2021, down 4.98%, and an annual FY2021 reading of 0.86, down 4.98% over the prior year.
  • Debt Ratio was 0.86 for Q4 2021 at Sunshine Biopharma, down from 1.28 in the prior quarter.
  • Across five years, Debt Ratio topped out at 1.28 in Q3 2021 and bottomed at 0.19 in Q3 2019.
  • Average Debt Ratio over 5 years is 0.64, with a median of 0.55 recorded in 2020.
  • The sharpest move saw Debt Ratio dropped 12.46% in 2018, then soared 245.09% in 2020.
  • Year by year, Debt Ratio stood at 0.31 in 2017, then decreased by 12.46% to 0.27 in 2018, then crashed by 30.55% to 0.19 in 2019, then skyrocketed by 382.31% to 0.91 in 2020, then dropped by 4.98% to 0.86 in 2021.
  • Business Quant data shows Debt Ratio for SBFM at 0.86 in Q4 2021, 1.28 in Q3 2021, and 1.13 in Q2 2021.